Answers are grounded in this paper and cite their sources.
Colony-stimulating factor 1 receptor (CSF1R)-dependent monocytes and macrophages are key mediators of chronic graft-versus-host disease (GVHD), a major long-term complication of allogeneic hematopoietic stem-cell transplantation. The CSF1R-blocking antibody axatilimab has shown promising clinical activity in chronic GVHD.
No takes yet. Share an insight, caveat, or question.
Wolff et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: